How to buy Afya stock - 21 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Afya stock

Own Afya stock in just a few minutes.

Afya Limited is an education & training services business based in the US. Afya shares (AFYA) are listed on the NASDAQ and all prices are listed in US Dollars. Afya employs 3,369 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Afya

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AFYA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Afya share price

Use our graph to track the performance of AFYA stocks over time.

Afya shares at a glance

Information last updated 2021-03-29.
52-week range$16.22 - $29.02
50-day moving average $21.94
200-day moving average $24.47
Wall St. target price$26.00
PE ratio 53.8695
Dividend yield N/A (0%)
Earnings per share (TTM) $0.80

Buy Afya shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
N/A
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Afya stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Afya under- or over-valued?

Valuing Afya stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Afya's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Afya's P/E ratio

Afya's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 54x. In other words, Afya shares trade at around 54x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Afya's EBITDA

Afya's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $73.8 million.

The EBITDA is a measure of a Afya's overall financial performance and is widely used to measure a its profitability.

Afya financials

Revenue TTM $195.5 million
Operating margin TTM 31.05%
Gross profit TTM $441.8 million
Return on assets TTM 5.97%
Return on equity TTM 12.46%
Profit margin 26.48%
Book value N/A
Market capitalisation $1.8 billion

TTM: trailing 12 months

Shorting Afya shares

There are currently 847,771 Afya shares held short by investors – that's known as Afya's "short interest". This figure is 5.4% up from 804,342 last month.

There are a few different ways that this level of interest in shorting Afya shares can be evaluated.

Afya's "short interest ratio" (SIR)

Afya's "short interest ratio" (SIR) is the quantity of Afya shares currently shorted divided by the average quantity of Afya shares traded daily (recently around 181535.54603854). Afya's SIR currently stands at 4.67. In other words for every 100,000 Afya shares traded daily on the market, roughly 4670 shares are currently held short.

However Afya's short interest can also be evaluated against the total number of Afya shares, or, against the total number of tradable Afya shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Afya's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Afya shares in existence, roughly 10 shares are currently held short) or 0.0204% of the tradable shares (for every 100,000 tradable Afya shares, roughly 20 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Afya.

Find out more about how you can short Afya stock.

Afya share dividends

We're not expecting Afya to pay a dividend over the next 12 months.

Afya overview

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company provides educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil and mechanical engineering, industrial engineering, dentistry, pedagogy, nutrition, physiotherapy, psychology, architecture, veterinary medicine, and others. In addition, the company provides distance learning residency preparatory courses through its online platform; and develops and sells printed and digital medical education content. As of December 31, 2019, it operated a network of 19 undergraduate and graduate medical school campuses consisted of 12 operating units and seven approved units. The company was founded in 1999 and is headquartered in Nova Lima, Brazil. .

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site